OakChart

908 Devices Inc

MASSHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 3:59 PM ET

10.06+0.08 (0.75%)
2026-11-11 22:44 CET
Market cap
412.72 USD m
Revenue, TTM
65.78 USD m
Net income, TTM
-24.15 USD m
Free cash flow, TTM
2.50 USD m
EPS diluted, TTM
-0.64
P/E
-
Compare

Price

MASS against its 20, 50 and 200-day averages
2050200beatmiss
8.0010.0012.00810K1.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MASSclose 10.0620-day 11.3050-day 11.18200-day 8.5310.0652w high

24.6% under the 52-week high of 13.35 on 6 Oct 2026. 52-week low 5.03 on 2 Jan 2026. Last 15 sessions, 31.8% high to low

Volume 1.23× normal · the line is the 50-bar volume average

Profile

MASS
52-week range, 60% of the way up
5.0313.35

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Burlington, MA.

IndexRUT
Employees172
IPODec 18, 2020
Beta0.63
ATR, 14d0.85
Rel volume1.23
Short float7.79%
Insider own20.91%
Inst own69.30%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap415.82M
Enterprise Value320.43M
Income-24.15M
Sales65.78M
Book/sh3.62
Cash/sh2.43
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees172
IPODec 18, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S6.32
P/B2.78
P/C4.14
P/FCF166.33
EV/EBITDA-
EV/Sales4.87
Quick Ratio4.84
Current Ratio5.43
Debt/Eq0.03
LT Debt/Eq0.03
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.64
EPS next Y-0.52
EPS next Q-0.14
EPS this Y-493.27%
EPS next Y43.17%
EPS next 5Y-
EPS past 3/5Y1.43% -16.61%
Sales past 3/5Y6.25% 15.88%
EPS Y/Y TTM63.00%
Sales Y/Y TTM14.14%
EPS Q/Q73.00%
Sales Q/Q35.31%
EarningsNov 10 BMO
EPS/Sales Surpr.61.13% 3.52%

Ownership

Insider Own20.91%
Insider Trans-9.28%
Inst Own69.30%
Inst Trans3.66%
ROA-12.27%
ROE-16.74%
ROIC-15.67%
Gross Margin48.74%
Oper. Margin-33.17%
Profit Margin-36.71%
SMA20-10.94%
SMA50-10.03%
SMA20017.94%
Trades-

Technical

Shs Outstand41.42M
Shs Float32.69M
Short Float7.79%
Short Ratio5.85
Short Interest2.55M
52W High13.35 -24.63%
52W Low5.03 100.20%
Volatility10.09% 7.16%
ATR (14)0.85
RSI (14)42.17
Beta0.63
Rel Volume1.23
Avg Volume435.60K
Volume534,199

Performance

Perf Week-9.12%
Perf Month-16.79%
Perf Quarter-0.49%
Perf Half Y33.42%
Perf YTD91.62%
Perf Year70.65%
Perf 3Y91.62%
Perf 5Y-68.56%
Perf 10Y-
Recom1.00
Target Price14.00
Prev Close9.98
Price10.06
Change %0.75%

Analyst ratings

latest 10 of 10
DateActionAnalystRating changeTargetImplied
Sep 10, 2026InitiatedCCanaccord GenuityBuy$13.50+34.2%
Jul 29, 2026InitiatedRRoth CapitalBuy$11+9.3%
Aug 05, 2025UpgradeLLeerink PartnersMarket Perform → Outperform$12+19.3%
Nov 13, 2024DowngradeLLeerink PartnersOutperform → Market Perform$12 → $4-60.2%
Feb 07, 2023InitiatedSStephensOverweight$14+39.2%
Oct 15, 2021ResumedCCowenOutperform
Jan 12, 2021InitiatedWWilliam BlairOutperform
Jan 12, 2021InitiatedSSVB LeerinkOutperform$70+595.8%
Jan 12, 2021InitiatedSStifelBuy$65+546.1%
Jan 12, 2021InitiatedCCowenOutperform

Peers

Mkt cap
TickerCompanyMkt cap
BRKRBruker Corp9.53B
VREXVarex Imaging Corp780.90M
LABStandard BioTools Inc253.85M
TMOThermo Fisher Scientific Inc265.92B
TDYTeledyne Technologies Inc29.98B
MIRMirion Technologies Inc4.35B
OSISOSI Systems Inc3.09B
CDRECadre Holdings Inc1.46B
MSAMSA Safety Inc6.79B
DRSLeonardo DRS Inc9.77B

Insider trading

latest 14 of 74
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Brown Christopher D.DirectorNov 04 '26Sale10.9530,000328,500775,559Nov 06 04:30 PM
Brown Christopher D.DirectorOct 07 '26Option Exercise1.7560,000105,000805,559Oct 09 04:15 PM
Brown Christopher D.DirectorOct 07 '26Sale11.8930,000356,700745,559Oct 09 04:15 PM
Griffith Joseph H. IVChief Financial OfficerOct 06 '26Sale13.035,00065,150116,497Oct 08 04:43 PM
Joseph GriffithOfficerOct 06 '26Proposed Sale12.805,00064,000Oct 06 04:25 PM
AWM Investment Company, Inc.10% OwnerSep 29 '26Sale11.5218,000207,3224,736,773Oct 01 05:02 PM
AWM Investment Company, Inc.10% OwnerSep 24 '26Sale11.3624,000272,6264,754,773Sep 25 04:19 PM
AWM Investment Company, Inc.10% OwnerSep 23 '26Sale11.251,00011,2504,755,773Sep 25 04:19 PM
Kenneweg JohnSVP, Sales & Product MarketingSep 16 '26Option Exercise0.9621,39920,54379,183Sep 17 05:27 PM
Kenneweg JohnSVP, Sales & Product MarketingSep 17 '26Option Exercise0.965,2575,04763,041Sep 17 05:27 PM
Kenneweg JohnSVP, Sales & Product MarketingSep 15 '26Option Exercise0.961,00096058,784Sep 17 05:27 PM
Kenneweg JohnSVP, Sales & Product MarketingSep 16 '26Sale10.1121,399216,34457,784Sep 17 05:27 PM
Kenneweg JohnSVP, Sales & Product MarketingSep 17 '26Sale10.225,25753,72757,784Sep 17 05:27 PM
Kenneweg JohnSVP, Sales & Product MarketingSep 15 '26Sale10.001,00010,00057,784Sep 17 05:27 PM

Held by

AUM
TickerCompanyAUM
ARKGARK Genomic Revolution ETFAUM: 1.97B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IWCiShares Micro-Cap ETFAUM: 1.22B
FITEState Street SPDR S&P Kensho Future Security ETFAUM: 148.02M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.058-0.150-0.11018.9518.315
2026Q22026-08-11-0.320-0.142-0.31516.0715.375
2026Q12026-05-06-0.082-0.140-0.32513.3813.164
2025Q42026-03-030.011-0.0740.11017.3815.844
2025Q32025-11-10-0.041-0.145-0.41314.0113.574
2025Q22025-08-05-0.360-0.170-0.37113.0412.174
2025Q12025-05-13-0.280-0.280-0.36711.8011.434
2024Q42025-03-04-0.560-0.345-0.56118.8216.715
2024Q32024-11-12-0.840-0.283-0.84516.7718.325
2024Q22024-08-06-0.370-0.337-0.36814.0513.695
2024Q12024-04-30-0.330-0.362-0.3349.999.295
2023Q42024-03-05-0.230-0.264-0.22914.3514.165
2023Q32023-11-07-0.220-0.302-0.21914.3013.455
2023Q22023-08-08-0.290-0.333-0.29012.0910.395
2023Q12023-05-09-0.390-0.348-0.3929.498.715
2022Q42023-03-07-0.310-0.258-0.30811.6011.435

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-2.067-0.343-0.47326.9026.43
2021FY-0.790-0.815-0.79342.2041.49
2022FY-1.070-1.014-1.06646.9046.63
2023FY-1.130-1.164-1.12950.2350.03
2024FY-2.120-1.676-2.11959.6357.51
2025FY-0.154-0.620-0.93056.2054.65
2026FY--0.915--69.19
2027FY--0.520--82.10
2028FY--0.390--94.20
2029FY--0.200--101.8

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1060320.9820.6022.00
2026Q4S2026-10-2560021.2920.7022.00
2026Q4S2026-09-0962221.2920.7022.00
2026Q4S2026-08-1152221.1520.7021.80
2026Q4S2026-07-2850021.2920.4022.23
2026Q4S2026-07-2040021.1820.4022.23
2026Q4S2026-05-0643121.1820.4022.23
2026Q4S2026-03-0342020.4119.5021.30
2026Q4S2026-01-2430019.1717.8020.91
2026Q4S2025-11-1131119.1717.8020.91
2026Q4S2025-11-1031119.1717.8020.91
2026Q4R2026-11-10110-0.08-0.08-0.08
2026Q4R2026-10-25100-0.12-0.12-0.12
2026Q4R2026-08-11101-0.12-0.12-0.12

Estimate history

EPS, annual-0.291-0.515-0.473-0.793-1.066-1.129-2.119-1.021-0.6416
Period20182019202020212022202320242025TTM
EPS, quarterly-0.845-0.561-0.367-0.371-0.4130.11-0.325-0.315-0.112
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual22.05417.97226.89442.20646.85250.22947.74656.19765.78
Period20182019202020212022202320242025TTM
Sales, quarterly16.77318.8211.77713.03514.00517.3813.38116.07418.95
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual26.20126.20127.27331.07731.8632.51935.09836.32241.419
Period20182019202020212022202320242025MRQ
Shares, quarterly34.71235.09835.7436.05836.11936.32237.41438.05941.419
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue65.7856.2047.7550.2346.8542.2126.8917.9722.05
Cost of Goods Sold Incl. D&A33.7229.4026.2426.8622.2818.9711.979.839.66
Gross Profit32.0726.8021.5123.3724.5823.2314.928.1412.39
Selling, General and Administrative Excl. Other53.8850.9851.4665.7759.8045.3020.7420.2918.83
Research and Development12.6913.8012.2120.4016.2513.078.238.999.53
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-21.82-24.18-29.95-42.40-35.22-22.07-5.82-12.14-6.44
Interest Expense0.000.000.000.200.130.310.981.531.15
Unusual Expense6.2615.2427.440.360.16-6.22-6.10-0.100.10
Net Income Before Taxes-24.22-33.34-53.14-36.61-33.56-22.17-12.82-13.37-7.54
Income Taxes-0.27-0.070.00-0.210.000.000.000.000.00
Consolidated Net Income-23.95-33.28-53.14-36.40-33.56-22.17-12.82-13.37-7.54
Net Income From Continuing Operations-23.95-33.28-53.14-36.40-33.56-22.17-12.82-13.37-7.54
Net Income-24.15-36.64-72.21-36.40-33.56-22.17-12.91-13.48-7.61
EPS (Recurring)-0.48-0.72-1.56-1.12-1.06-0.95-0.63-0.52-0.29
EPS (Basic, Before Extraordinaries)-0.63-1.02-2.12-1.13-1.07-0.79-0.47-0.51-0.29
EPS (Diluted)-0.64-1.02-2.12-1.13-1.07-0.79-0.47-0.51-0.29
EBITDA-16.70-19.71-25.27-40.02-33.61-21.14-4.98-11.24-5.54
Non-Operating Income (Expense)3.766.084.256.351.95-6.01-12.130.200.15
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense8.267.664.707.737.212.500.530.270.22
Price To Sales Ratio7.703.351.577.205.1217.1457.75--
Gross Margin48.7447.6845.0546.5252.4555.0555.4945.3156.19
Operating Margin-33.17-43.03-62.73-84.42-75.18-52.29-21.62-67.57-29.20
Net Margin-36.71-65.20-151.23-72.47-71.64-52.53-48.00-75.02-34.52
Shares Outstanding41.4236.3235.1032.5231.8631.0827.2726.2026.20
Market Capitalization412.72412.7276.61363.29241.64803.261,492.141,582.00-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue18.9516.0713.3817.3814.0113.0411.7818.82
Cost of Goods Sold Incl. D&A9.658.367.008.717.117.006.8910.39
Gross Profit9.307.726.388.676.906.044.888.43
Selling, General and Administrative Excl. Other15.0814.0812.8811.8412.416.3013.3119.62
Research and Development3.343.173.063.123.384.153.256.02
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-5.78-6.37-6.50-3.17-5.52-0.27-8.43-11.19
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense-0.306.446.38-6.2610.8114.892.609.06
Net Income Before Taxes-4.63-11.95-11.964.32-14.88-12.84-9.84-19.52
Income Taxes-0.05-0.050.00-0.170.030.070.00-0.07
Consolidated Net Income-4.58-11.89-11.964.48-14.91-12.91-9.84-19.45
Net Income From Continuing Operations-4.58-11.89-11.964.48-14.91-12.91-9.84-19.45
Net Income-4.58-11.89-11.964.28-14.91-13.31-12.99-19.45
EPS (Recurring)-0.12-0.20-0.20-0.00-0.20-0.08-0.32-0.38
EPS (Basic, Before Extraordinaries)-0.11-0.32-0.320.12-0.41-0.37-0.37-0.56
EPS (Diluted)-0.11-0.32-0.320.11-0.41-0.37-0.37-0.56
EBITDA-4.28-5.01-5.36-2.05-4.420.70-7.14-9.78
Non-Operating Income (Expense)0.850.860.931.121.442.321.190.74
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.851.832.402.191.882.342.222.23
Price To Sales Ratio7.705.393.903.645.494.232.581.28
Gross Margin49.0848.0047.6649.9049.2646.3041.4844.78
Operating Margin-30.51-39.61-48.60-18.22-39.39-2.06-71.55-59.47
Net Margin-24.16-74.00-89.3424.61-106.46-102.08-110.34-103.33
Shares Outstanding41.4238.0637.4136.3236.1236.0635.7435.10
Market Capitalization412.72328.98228.77190.01316.11255.69158.2876.61

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments112.9768.92145.68188.48224.13159.2317.917.07
Short Term Receivables11.338.858.9910.4316.576.875.086.34
Inventories12.9910.8914.9412.517.924.575.243.52
Other Current Assets7.2714.394.184.204.270.300.350.27
Total Current Assets144.56103.06173.79215.63252.89170.9728.5817.20
Net Property, Plant & Equipment8.635.449.577.046.797.148.5710.01
Total Investments and Advances0.070.170.170.000.000.000.000.00
Intangible Assets36.4138.6818.2318.54----
Other Assets0.4012.131.221.381.230.720.510.53
Total Assets190.07159.48202.98242.59260.91178.8337.6627.75
Short Term Debt Incl. Current Port. of LT Debt0.681.472.021.471.341.691.080.31
Accounts Payable1.591.371.191.401.371.000.580.65
Other Current Liabilities31.8022.3119.3416.3612.128.144.403.80
Total Current Liabilities34.0625.1522.5519.2314.8410.836.054.76
Long Term Debt3.952.603.9318.0419.5120.1721.7117.62
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities-2.032.442.67----
Other Liabilities8.3617.148.5712.0511.968.782.052.45
Total Liabilities46.3744.8837.4951.9946.3039.7929.8124.84
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.0071.0253.09
Common Equity143.70114.59165.49190.60214.60139.04-63.17-50.18
Total Shareholders Equity143.70114.59165.49190.60214.60139.047.852.91
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity143.70114.59165.49190.60214.60139.047.852.91
Total Liabilities & Stockholders Equity190.07159.48202.98242.59260.91178.8337.6627.75
Book Value Per Share3.963.265.095.986.915.10-2.41-1.92
Tangible Book Value Per Share2.952.164.535.406.915.10-2.41-1.92
Full-Time Employees172246230685640--
Price to Book Ratio2.760.582.141.233.7511.17-24.11-
Return on Assets-19.04-29.32-16.34-13.33-10.08-11.84-40.89-
Return on Equity-25.77-37.95-20.44-16.57-12.54-17.45-248.52-
Return on Invested Capital-24.82-61.61-21.48-16.09-9.47-8.05-45.24-36.70
Quick Ratio3.863.667.0410.5616.5115.363.862.87
Current Ratio4.244.107.7111.2217.0515.784.723.61

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-24.2519.49-72.21-36.40-33.56-22.17-12.82-13.37-7.54
Depreciation5.114.464.682.381.610.930.830.900.90
Other Funds (Non Cash)17.24-32.3440.1010.837.794.606.080.730.87
Funds from Operations-2.00-8.39-27.70-23.49-24.29-16.65-5.91-11.75-5.77
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital4.77-15.30-2.54-1.573.36-12.4410.040.74-3.13
Cash from Operating Activities2.76-23.69-30.25-25.06-20.93-29.084.13-11.00-8.90
Capital Expenditures-0.26-0.95-0.60-2.04-2.04-0.74-0.01-0.39-0.73
Net Assets From Acquisitions-12.52-2.00-44.780.00-13.760.000.000.000.00
Sale of Fixed Assets and Businesses0.0069.910.000.000.000.000.000.000.00
Purchase or Sale of Investments13.23-16.21-0.94-24.360.000.000.000.000.00
Purchase of Investments-44.80-64.00-55.50-48.870.000.000.000.000.00
Sale Or Maturity of Investments58.0347.8054.5624.520.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00-0.44
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities0.4550.75-46.32-26.40-15.81-0.74-0.01-0.39-1.17
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock2.300.861.150.941.440.850.0517.323.99
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock2.300.861.150.941.440.850.0517.323.99
Proceedsfrom Stock Options0.000.000.000.00-0.110.000.0017.323.92
Issuance or Reduction of Debt, Net0.000.000.00-15.000.00-0.040.004.920.00
Change in Long Term Debt0.000.000.00-15.000.00-0.040.004.920.00
Issuance of Long Term Debt0.000.000.000.0060.0029.962.2014.920.00
Reduction of Long Term Debt0.000.000.00-15.00-60.00-30.00-2.20-10.000.00
Net Financing Active Other Cash Flow-3.29-1.56-1.52-1.87-0.2693.91137.140.000.00
Other Financing Activities Uses-3.29-1.56-1.52-1.87-0.26-0.84-1.900.000.00
Cash from Financing Activities-0.98-0.70-0.38-15.941.1894.72137.1922.243.99
Exchange Rate Effect-0.100.03-0.070.010.02----
Net Change in Cash2.1226.39-77.01-67.38-35.5464.91141.3110.84-6.07
Free Cash Flow2.50-24.64-30.85-27.10-22.98-29.824.12-11.40-9.62
Preferred Dividends (Cash Flow)-0.000.000.000.000.00---
Price to Free Cash Flow202.55-----376.81--
Deferred Taxes & Investment Tax Credit-0.00-0.28-0.30-0.130.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments100.44102.84111.74112.97112.05118.58
Short Term Receivables17.2211.719.8711.3311.006.21
Inventories14.6914.3713.2412.9915.3315.46
Other Current Assets2.793.107.177.276.567.61
Total Current Assets135.15132.02142.01144.56144.94147.87
Net Property, Plant & Equipment9.178.618.358.638.305.95
Total Investments and Advances0.070.070.070.070.070.14
Intangible Assets54.3156.1735.6836.4137.1437.25
Other Assets0.660.660.580.400.420.50
Total Assets199.36197.54186.69190.07190.87191.70
Short Term Debt Incl. Current Port. of LT Debt0.680.720.700.680.480.43
Accounts Payable2.762.712.421.591.813.58
Other Current Liabilities21.4545.9936.5531.8039.1925.69
Total Current Liabilities24.8949.4239.6634.0641.4829.71
Long Term Debt4.373.583.773.953.874.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.800.88----
Other Liabilities19.5016.899.108.369.229.18
Total Liabilities49.5570.7752.5246.3754.5742.88
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity149.80126.77134.17143.70136.30148.82
Total Shareholders Equity149.80126.77134.17143.70136.30148.82
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity149.80126.77134.17143.70136.30148.82
Total Liabilities & Stockholders Equity199.36197.54186.69190.07190.87191.70
Book Value Per Share3.623.333.593.963.774.13
Tangible Book Value Per Share2.311.852.632.952.753.09
Full-Time Employees---172--
Price to Book Ratio2.762.431.551.392.121.60
Return on Assets-12.27-17.61-18.44-18.98-30.94-35.70
Return on Equity-16.74-24.88-24.04-25.69-42.72-46.85
Return on Invested Capital-2.97-9.12-8.672.90-10.64-8.71
Quick Ratio4.842.383.253.863.124.46
Current Ratio5.432.673.584.243.494.98

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-4.58-11.89-11.964.17-14.98-13.31
Depreciation1.501.361.141.111.090.97
Other Funds (Non Cash)2.599.058.76-3.1713.089.52
Funds from Operations-0.54-1.54-2.042.12-0.81-2.81
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-2.274.713.13-0.80-3.40-2.97
Cash from Operating Activities-2.813.171.081.32-4.20-5.78
Capital Expenditures-0.07-0.16-0.040.01-0.68-0.12
Net Assets From Acquisitions0.20-12.720.000.00-2.000.00
Sale of Fixed Assets and Businesses0.000.000.000.00-0.010.00
Purchase or Sale of Investments2.815.57-1.956.807.90-11.46
Purchase of Investments-11.72-5.00-18.35-9.735.14-35.10
Sale Or Maturity of Investments14.5410.5716.4016.532.7623.63
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities2.95-7.32-1.996.815.21-11.59
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.591.180.080.450.030.38
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.591.180.080.450.030.38
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.08-0.22-2.13-0.86-0.04-0.45
Other Financing Activities Uses-0.08-0.22-2.13-0.86-0.04-0.45
Cash from Financing Activities0.510.96-2.05-0.41-0.02-0.08
Exchange Rate Effect-0.05-0.060.000.000.000.00
Net Change in Cash0.60-3.24-2.957.710.99-17.45
Free Cash Flow-2.883.011.041.32-4.88-5.91
Price to Free Cash Flow202.55664.43----

Revenue breakdown

Contract2024: 132.00K 2025: 117.00K
Device Sales2024: 31.69M 2025: 36.66M
Recurring2024: 15.93M 2025: 19.42M
Americas other2024: 863.00K 2025: 1.53M
Asia Pacific2024: 2.10M 2025: 3.00M
EMEA2024: 9.13M 2025: 10.43M
United States2024: 35.65M 2025: 41.25M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.79%2.5M32.7M422.70K
2026-10-158.29%2.7M32.7M413.47K
2026-09-308.34%2.7M32.7M387.83K
2026-09-158.39%2.7M32.7M390.65K
2026-08-318.59%2.8M32.7M378.35K
2026-08-148.56%2.8M32.6M339.17K
2026-07-3111.01%3.4M30.8M302.38K
2026-07-1510.51%3.2M30.8M288.25K
2026-06-3010.86%3.1M28.4M294.67K
2026-06-1511.34%3.2M28.3M266.16K
2026-05-2911.23%3.2M28.3M282.36K
2026-05-1511.85%3.3M28.2M272.26K
2026-04-3012.35%3.5M28.2M274.45K
2026-04-1512.48%3.5M27.9M309.88K
2026-03-3113.14%3.6M27.6M314.59K
2026-03-1313.59%3.8M27.6M397.01K
2026-02-2714.50%3.9M26.7M395.79K
2026-02-1314.32%3.8M26.7M428.40K
2026-01-3011.93%3.2M26.7M441.53K
2026-01-1512.37%3.3M26.9M409.56K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.507.108.700.0013.1450.000.000.962-0.0550.001
call5.004.706.205.097.0501.000.000.922-0.0530.002
call7.502.153.704.304.1007.000.000.853-0.0450.004
call10.000.201.652.062.61324.000.000.568-0.0660.006
call12.500.000.750.452.4461680.000.353-0.0810.006
call15.000.000.750.573.20730.000.000.297-0.0990.005
call17.500.000.750.373.8613.000.000.268-0.1130.005
call20.000.000.750.004.3800.000.000.250-0.1220.005
put2.500.000.750.007.5590.000.00-0.037-0.0550.001
put5.000.000.750.404.1681.000.00-0.074-0.0530.002
put7.500.000.300.452.2353.000.00-0.137-0.0440.004
put10.000.050.750.881.26351.000.00-0.432-0.0650.006
put12.501.402.801.001.7576000.00-0.647-0.0790.006
put15.004.005.403.002.7161000.00-0.703-0.0980.005
put17.506.407.800.003.0620.000.00-0.732-0.1110.005
put20.008.9010.300.003.5180.000.00-0.750-0.1200.005

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-10-27SCHEDULE 13G/ASEC
2026-10-094Statement of changes in beneficial ownership of securities2026-10-07SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-06SEC
2026-10-06144Filing for proposed sale of securities under Rule 144.SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-29SEC
2026-09-254Statement of changes in beneficial ownership of securities2026-09-23SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-25144Filing for proposed sale of securities under Rule 144.SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-10144Filing for proposed sale of securities under Rule 144.SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-064Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-07-27SCHEDULE 13GSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100328.50K1
2026-1000421.85K2
2026-09001.09M7
2026-08003.16M12
2026-070021.86K2
2026-06001.29M11
2026-05002.96M11
2026-0400470.25K6
2026-0300491
2026-0200358.06K2
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
First Light Asset Management, LLC16.62%
AWM Investment Company, Inc.12.90%
ARK Investment Management LLC5.36%
BlackRock, Inc.5.14%
NEEDHAM INVESTMENT MANAGEMENT LLC4.81%
VANGUARD CAPITAL MANAGEMENT LLC3.42%
First Eagle Investment Management, LLC2.12%
GEODE CAPITAL MANAGEMENT, LLC1.93%
Granahan Investment Management, LLC1.83%
STATE STREET CORP1.60%

Funds

Fund% owned
ARK Genomic Revolution ETF4.64%
Needham Aggressive Growth Fund3.70%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.43%
First Eagle Small Cap Opportunity Fund2.10%
iShares Russell 2000 ETF2.00%
Avantis U.S. Small Cap Value ETF1.77%
VANGUARD EXTENDED MARKET INDEX FUND0.90%
Fidelity Small Cap Index Fund0.77%
iShares Russell 2000 Value ETF0.69%
Needham Small Cap Growth Fund0.67%

OakChart. MASS. Cached 15 minutes.